201 related articles for article (PubMed ID: 18241035)
1. Breast cancer-associated mutations in metalloprotease disintegrin ADAM12 interfere with the intracellular trafficking and processing of the protein.
Dyczynska E; Syta E; Sun D; Zolkiewska A
Int J Cancer; 2008 Jun; 122(11):2634-40. PubMed ID: 18241035
[TBL] [Abstract][Full Text] [Related]
2. Phenotypic diversity of breast cancer-related mutations in metalloproteinase-disintegrin ADAM12.
Qi Y; Duhachek-Muggy S; Li H; Zolkiewska A
PLoS One; 2014; 9(3):e92536. PubMed ID: 24651654
[TBL] [Abstract][Full Text] [Related]
3. Functional analysis of a breast cancer-associated mutation in the intracellular domain of the metalloprotease ADAM12.
Stautz D; Wewer UM; Kveiborg M
PLoS One; 2012; 7(5):e37628. PubMed ID: 22662180
[TBL] [Abstract][Full Text] [Related]
4. A positive feedback loop between HER2 and ADAM12 in human head and neck cancer cells increases migration and invasion.
Rao VH; Kandel A; Lynch D; Pena Z; Marwaha N; Deng C; Watson P; Hansen LA
Oncogene; 2012 Jun; 31(23):2888-98. PubMed ID: 21986939
[TBL] [Abstract][Full Text] [Related]
5. ADAM12 induces estrogen-independence in breast cancer cells.
Roy R; Moses MA
Breast Cancer Res Treat; 2012 Feb; 131(3):731-41. PubMed ID: 21387162
[TBL] [Abstract][Full Text] [Related]
6. RACK1, a new ADAM12 interacting protein. Contribution to liver fibrogenesis.
Bourd-Boittin K; Le Pabic H; Bonnier D; L'Helgoualc'h A; Théret N
J Biol Chem; 2008 Sep; 283(38):26000-9. PubMed ID: 18621736
[TBL] [Abstract][Full Text] [Related]
7. ADAM12-L is a direct target of the miR-29 and miR-200 families in breast cancer.
Duhachek-Muggy S; Zolkiewska A
BMC Cancer; 2015 Mar; 15():93. PubMed ID: 25886595
[TBL] [Abstract][Full Text] [Related]
8. Cellular roles of ADAM12 in health and disease.
Kveiborg M; Albrechtsen R; Couchman JR; Wewer UM
Int J Biochem Cell Biol; 2008; 40(9):1685-702. PubMed ID: 18342566
[TBL] [Abstract][Full Text] [Related]
9. An essential role of metalloprotease-disintegrin ADAM12 in triple-negative breast cancer.
Li H; Duhachek-Muggy S; Qi Y; Hong Y; Behbod F; Zolkiewska A
Breast Cancer Res Treat; 2012 Oct; 135(3):759-69. PubMed ID: 22926263
[TBL] [Abstract][Full Text] [Related]
10. Molecular profiling of ADAM12 gene in breast cancers.
Nariţa D; Anghel A; Seclaman E; Ilina R; Cireap N; Ursoniu S
Rom J Morphol Embryol; 2010; 51(4):669-76. PubMed ID: 21103624
[TBL] [Abstract][Full Text] [Related]
11. ADAM12 produced by tumor cells rather than stromal cells accelerates breast tumor progression.
Fröhlich C; Nehammer C; Albrechtsen R; Kronqvist P; Kveiborg M; Sehara-Fujisawa A; Mercurio AM; Wewer UM
Mol Cancer Res; 2011 Nov; 9(11):1449-61. PubMed ID: 21875931
[TBL] [Abstract][Full Text] [Related]
12. ADAM12: a potential target for the treatment of chronic wounds.
Harsha A; Stojadinovic O; Brem H; Sehara-Fujisawa A; Wewer U; Loomis CA; Blobel CP; Tomic-Canic M
J Mol Med (Berl); 2008 Aug; 86(8):961-9. PubMed ID: 18604515
[TBL] [Abstract][Full Text] [Related]
13. Alternative mRNA splicing generates two distinct ADAM12 prodomain variants.
Duhachek-Muggy S; Li H; Qi Y; Zolkiewska A
PLoS One; 2013; 8(10):e75730. PubMed ID: 24116070
[TBL] [Abstract][Full Text] [Related]
14. Proteolytic processing of delta-like 1 by ADAM proteases.
Dyczynska E; Sun D; Yi H; Sehara-Fujisawa A; Blobel CP; Zolkiewska A
J Biol Chem; 2007 Jan; 282(1):436-44. PubMed ID: 17107962
[TBL] [Abstract][Full Text] [Related]
15. Metalloprotease-disintegrin ADAM12 actively promotes the stem cell-like phenotype in claudin-low breast cancer.
Duhachek-Muggy S; Qi Y; Wise R; Alyahya L; Li H; Hodge J; Zolkiewska A
Mol Cancer; 2017 Feb; 16(1):32. PubMed ID: 28148288
[TBL] [Abstract][Full Text] [Related]
16. ADAM12 and ADAM17 gene expression in laser-capture microdissected and non-microdissected breast tumors.
Narita D; Seclaman E; Ilina R; Cireap N; Ursoniu S; Anghel A
Pathol Oncol Res; 2011 Jun; 17(2):375-85. PubMed ID: 21240579
[TBL] [Abstract][Full Text] [Related]
17. The Disintegrin and Metalloprotease ADAM12 Is Associated with TGF-β-Induced Epithelial to Mesenchymal Transition.
Ruff M; Leyme A; Le Cann F; Bonnier D; Le Seyec J; Chesnel F; Fattet L; Rimokh R; Baffet G; Théret N
PLoS One; 2015; 10(9):e0139179. PubMed ID: 26407179
[TBL] [Abstract][Full Text] [Related]
18. A disintegrin and metalloproteinase 12 (ADAM12) localizes to invasive trophoblast, promotes cell invasion and directs column outgrowth in early placental development.
Aghababaei M; Perdu S; Irvine K; Beristain AG
Mol Hum Reprod; 2014 Mar; 20(3):235-49. PubMed ID: 24243624
[TBL] [Abstract][Full Text] [Related]
19. ADAM12 is a four-leafed clover: the excised prodomain remains bound to the mature enzyme.
Wewer UM; Mörgelin M; Holck P; Jacobsen J; Lydolph MC; Johnsen AH; Kveiborg M; Albrechtsen R
J Biol Chem; 2006 Apr; 281(14):9418-22. PubMed ID: 16455653
[TBL] [Abstract][Full Text] [Related]
20. ADAM12 is expressed in the tumour vasculature and mediates ectodomain shedding of several membrane-anchored endothelial proteins.
Fröhlich C; Klitgaard M; Noer JB; Kotzsch A; Nehammer C; Kronqvist P; Berthelsen J; Blobel C; Kveiborg M; Albrechtsen R; Wewer UM
Biochem J; 2013 May; 452(1):97-109. PubMed ID: 23458101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
